The two-dose vaccine has been shown to have benefits beyond just developing shingles, although that alone should be impetus ...

Patients 15 years of age and younger with herpes zoster ophthalmicus were included in the study from January 1999 to January 2005. The mean age of the 10 children (five boys, five girls) at ...

Herpes zoster ophthalmicus has a frequency ranging from 2.7% to 6.7% annually, with a consistent increase of 2.9% since 2012.

Persons at highest risk for complications are elderly persons, those with herpes zoster ophthalmicus, and immunocompromised patients. Older age, a greater degree of skin-surface area involved, ...

Of the cases referred to me for management of dry eye, many turn out to be manifestations of nerve damage subsequent to an untreated viral infection, such as herpes zoster ophthalmicus.Untreated ...

Source Reference: Walia A, et al "Risk of herpes zoster ophthalmicus recurrence after recombinant zoster vaccination" JAMA Ophthalmol 2024; DOI: 10.1001/jamaophthalmol.2023.6830.

How Is Herpes Zoster Ophthalmicus Treated? Because herpes is a virus, antibiotics such as penicillin are not an effective treatment. The only drugs that will work against herpes infections are ...

Herpes Zoster Ophthalmicus: Comparison of Disease in Patients 60 Years and Older Versus Younger Than 60 Years . Ghaznawi N, Virdi A, Dayan A, et al. Ophthalmology. 2011;118:2242-2250.

Herpes zoster ophthalmicus and other types of herpes zoster usually affect a single dermatome, because the virus lies dormant within a cranial nerve, dorsal root, ...

Herpes zoster reactivation -- a.k.a. shingles -- following COVID-19 vaccination in six patients with comorbid autoimmune/inflammatory diseases may be a new adverse event associated with the Pfizer ...